10795--11/25/2009--BECTON_DICKINSON_&

related topics

{regulation, government, change}

{product, liability, claim}

{customer, product, revenue}

{system, service, information}

{operation, international, foreign}

{financial, litigation, operation}

{product, market, service}

{stock, price, operating}

We are subject to foreign currency exchange risk. Proposals to reform the U.S. healthcare system may have a material adverse effect on us. Changes in reimbursement practices of third-party payers could affect the demand for our products and the prices at which they are sold. Price volatility could adversely affect the results of our operations. BD s future growth is dependent upon the development of new products, and there can be no assurance that such products will be developed. The medical technology industry is very competitive. A reduction or interruption in the supply of certain raw materials and components would adversely affect BD s manufacturing operations and related product sales. Interruption of our manufacturing operations could adversely affect BD s future revenues and operating income. BD is subject to a number of pending lawsuits. Consolidation in the healthcare industry could adversely affect BD s future revenues and operating income. Product defects could adversely affect the results of our operations. We may experience difficulties implementing our enterprise resource planning system. BD is subject to extensive regulation.

Full 10-K form ▸

10795--11/25/2009--BECTON_DICKINSON_&_CO